|
|||||
|
|
| 急性冠状动脉综合征非介入治疗中的抗血小板治疗 | |
| 引用本文： | 孙爱华,吴同果. 急性冠状动脉综合征非介入治疗中的抗血小板治疗[J]. 中国心血管杂志, 2007, 12(2): 141-143 |
| 作者姓名： | 孙爱华 吴同果 |
| 作者单位： | 广州市红十字会医院/暨南大学第四附属医院,广东,广州,510220 |
| 摘 要： | 急性冠状动脉综合征(ACS)的特征是冠状动脉斑块破裂、血小板活化和血栓形成.因此抗血小板药物在ACS治疗中有着重要的地位.本文综述了抗血小板治疗在ACS非介入治疗中的研究现状和进展. |
| 关 键 词： | 急性冠状动脉综合征 抗血小板药物 |
| 文章编号： | 1007-5410(2007)02-0141-03 |
| 修稿时间： | 2006-07-21 |
Antiplatelet therapy in patients with acute coronary syndrome |
|
| SUN Ai-hua,WU Tong-guo. Antiplatelet therapy in patients with acute coronary syndrome[J]. Chinese Journal of Cardiovascular Medicine, 2007, 12(2): 141-143 | |
| Authors: | SUN Ai-hua WU Tong-guo |
| Affiliation: | Department of cardiology ,Guangzhou Red Cross Hospital/The Fourth Affiliated Hospital of Jinan University, Guangdong Province ,Guangzhou 510220,China. |
| Abstract: | Acute coronary syndromes(ACS) are characterized by coronary arterial plaque rupture,platelet activation and thrombus formation.Antiplatelet agents play an important role in the treatment of ACS.The purpose of this article is to discuss the current status and progress of antiplatelet therapy in patients with ACS. |
| Keywords: | Acute coronary syndromes Antiplatelet agents |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |